🇨🇦 MK0826; ertapenem sodium in Canada

MK0826; ertapenem sodium (MK0826; ertapenem sodium) regulatory status in Canada.

Marketing authorisation

MK0826; ertapenem sodium in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is MK0826; ertapenem sodium approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for MK0826; ertapenem sodium in Canada?

Merck Sharp & Dohme LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.